Contineum Therapeutics Inc
NASDAQ:CTNM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Contineum Therapeutics Inc
NASDAQ:CTNM
|
US |
|
Equinor ASA
F:DNQ
|
NO |
|
C
|
Cornish Metals PLC
LSE:TIN
|
UK |
|
Abivax SA
PAR:ABVX
|
FR |
|
Amplitude Energy Ltd
F:CDP0
|
AU |
|
I
|
IBI-Lion SOCIMI SA
MAD:YIBI
|
ES |
|
Carrefour SA
F:CAR1
|
FR |
|
B
|
BHP Group Ltd
DUS:BHP1
|
AU |
|
H
|
H+H International A/S
CSE:HH
|
DK |
|
Tiong Seng Holdings Ltd
SGX:BFI
|
SG |
|
B
|
BNP Paribas SA
F:BNP
|
FR |
|
NJ Holdings Inc
TSE:9421
|
JP |
|
D
|
Dexcom Inc
SWB:DC4
|
US |
|
Paymentus Holdings Inc
NYSE:PAY
|
US |
|
A
|
Adani Ports and Special Economic Zone Ltd
BSE:532921
|
IN |
|
P
|
Public Storage
F:PUP
|
US |
|
Silicon Laboratories Inc
NASDAQ:SLAB
|
US |
|
Keystone Law Group PLC
LSE:KEYS
|
UK |
|
Canadian Tire Corporation Ltd
TSX:CTC.A
|
CA |
|
Novartis AG
SIX:NOVN
|
CH |
|
A
|
Ageas SA
XMUN:FO4N
|
BE |
|
ITV PLC
F:IJ70
|
UK |
|
S
|
Standard Bank Group Ltd
XMUN:SKC2
|
ZA |
|
G
|
General Motors Co
XMUN:8GM
|
US |
Bankruptcy Probability
Contineum Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Contineum Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
C
|
Contineum Therapeutics Inc
NASDAQ:CTNM
|
504m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
648.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
372.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
361.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
221.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
192.8B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
310.3B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
159.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
127.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Contineum Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Contineum Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.